Heinrich M, Hofmann L, Baurecht H, Kreuzer PM, Knüttel H, Leitzmann MF, Seliger C. Suicide risk and mortality among patients with cancer. Nat Med. 2022 Apr;28(4):852-859
Seliger C, Meyer AL, Leidgens V, Rauer L, Moeckel S, Jachnik B, Proske J, Dettmer K, Rothhammer-Hampl T, Kaulen LD, Riemenschneider MJ, Oefner PJ, Kreutz M, Schmidt NO, Merrill M, Uhl M, Renner K, Vollmann-Zwerenz A, Proescholdt M, Hau P. Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin. Int J Mol Sci. 2022 Oct 1;23(19):11629
Schmid D, Warnken U, Latzer P, Hoffmann DC, Roth J, Kutschmann S, Jaschonek H, Rübmann P, Foltyn M, Vollmuth P, Winkler F, Seliger C, Felix M, Sahm F, Haas J, Reuss D, Bendszus M, Wildemann B, von Deimling A, Wick W, Kessler T. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies. J Neurochem. 2021 Jul;158(2):522-538
Doubrovinskaia S, Sahm F, Thier MC, Bendszus M, Wick W, Seliger C*, Kaulen LD*. Primary CNS lymphoma after CLIPPERS: a case series. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1348-1349
Dirven L, Luerding R, Beier D, Bumes E, Reinert C, Seidel C, Bonsanto MM, Bremer M, Rieken S, Combs SE, Herrlinger U, Seliger C, Kuntze H, Mayer-Steinacker R, Dieing A, Bartels C, Schnell O, Weyerbrock A, Seidel S, Grauer O, Nadji-Ohl M, Paulsen F, Weller M, Wick W, Hau P. Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study. J Neurooncol. 2020 May;148(1):117-130
Seliger C, Genbrugge E, Gorlia T, Chinot O, Stupp R, Nabors B, Weller M and Hau P. Pooled analysis of prospective clinical trials for an association of metformin use with outcome in patients with newly diagnosed glioblastoma. Int J Cancer. 2020 Feb 1;146(3):803-809
Seliger C, Luber C, Gerken M, Schaertl J, Proescholdt M, Riemenschneider MJ, Meier CR, Bogdahn U, Leitzmann MF, Klinkhammer-Schalke M and Hau P. Use of metformin and survival of patients with high-grade glioma. Int J Cancer 2019 Jan 15;144(2):273-280
Moeckel S, LaFrance K, Wetsch J, Seliger C, Riemenschneider M, Proescholdt M, Hau P and Vollmann-Zwerenz A. ATF4 contributes to autophagy and survival in Sunitinib treated Brain Tumor Initiating Cells (BTICs). Oncotarget 2019 Jan 8;10(3):368-382
Merkel A, Soeldner D, Wendl C, Urkan D, Kuramatsu JB, Seliger C, Proescholdt M, Eyupoglu IY, Hau P and Uhl M. Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials. J Neurooncol 2017 Apr;132(2):249-254
Leidgens V, Proske J, Rauer L, Moeckel S, Renner K, Bogdahn U, Riemenschneider JM, Proescholdt M, Vollmann-Zwerenz A, Hau P and Seliger C. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation. Oncotarget 2017 Jan 31;8(5):8250-8263
Seliger C, Ricci C, Meier CR, Bodmer M, Jick SS, Bogdahn U, et al. Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro Oncol 2016 Mar;18(3):340-9
Seliger C, Meier CR, Becker C, Bogdahn U, Hau P and Leitzmann MF. Statin use and risk of glioma - population-based case-control analysis. Eur J Epidemiology 2016 Sep;31(9):947-52
Seliger C, Schulte-Mattler W, Bogdahn U, Uhl M. Clinical reasoning: a 49-year-old man with fever and proximal weakness of his arms. Neurology 2014 Feb 25;82(8):e65-9
Seliger C, Leukel P, Moeckel S, Jachnik B, Lottaz C, Kreutz M, et al. Lactate Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro. PloS one 2013 Nov 1;8(11):e78935